1. Home
  2. BIVI vs ANY Comparison

BIVI vs ANY Comparison

Compare BIVI & ANY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIVI
  • ANY
  • Stock Information
  • Founded
  • BIVI 2013
  • ANY N/A
  • Country
  • BIVI United States
  • ANY United States
  • Employees
  • BIVI N/A
  • ANY N/A
  • Industry
  • BIVI Biotechnology: Pharmaceutical Preparations
  • ANY Finance: Consumer Services
  • Sector
  • BIVI Health Care
  • ANY Finance
  • Exchange
  • BIVI Nasdaq
  • ANY Nasdaq
  • Market Cap
  • BIVI 18.6M
  • ANY 17.7M
  • IPO Year
  • BIVI N/A
  • ANY N/A
  • Fundamental
  • Price
  • BIVI $1.02
  • ANY $0.60
  • Analyst Decision
  • BIVI Strong Buy
  • ANY Strong Buy
  • Analyst Count
  • BIVI 1
  • ANY 1
  • Target Price
  • BIVI $30.00
  • ANY $3.00
  • AVG Volume (30 Days)
  • BIVI 194.8K
  • ANY 368.2K
  • Earning Date
  • BIVI 05-12-2025
  • ANY 08-12-2025
  • Dividend Yield
  • BIVI N/A
  • ANY N/A
  • EPS Growth
  • BIVI N/A
  • ANY N/A
  • EPS
  • BIVI N/A
  • ANY N/A
  • Revenue
  • BIVI N/A
  • ANY $12,479,000.00
  • Revenue This Year
  • BIVI N/A
  • ANY N/A
  • Revenue Next Year
  • BIVI N/A
  • ANY N/A
  • P/E Ratio
  • BIVI N/A
  • ANY N/A
  • Revenue Growth
  • BIVI N/A
  • ANY N/A
  • 52 Week Low
  • BIVI $0.62
  • ANY $0.36
  • 52 Week High
  • BIVI $7.50
  • ANY $1.90
  • Technical
  • Relative Strength Index (RSI)
  • BIVI 47.95
  • ANY 41.81
  • Support Level
  • BIVI $1.00
  • ANY $0.62
  • Resistance Level
  • BIVI $1.09
  • ANY $0.79
  • Average True Range (ATR)
  • BIVI 0.07
  • ANY 0.05
  • MACD
  • BIVI -0.01
  • ANY -0.02
  • Stochastic Oscillator
  • BIVI 19.05
  • ANY 33.71

About BIVI BioVie Inc.

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

About ANY Sphere 3D Corp.

Sphere 3D Corp provides solutions for stand-alone storage and technologies that converge the traditional silos of compute, storage, and network into integrated hyper-converged or converged solution. Its Disk systems include HVE Converged and Hyper-converged Infrastructure. It generates the majority of its revenue from the services it offers. All of its revenue comes from the Americas. The Company has two operating segments: Bitcoin Mining and Service and Product. The Bitcoin Mining segment generates revenue from the digital currency, it earns through its bitcoin mining activities. The Service and Product segment generates revenue from long-term customer contracts for service contracts and extended service contract and the sale of products related to the Company's data storage product line.

Share on Social Networks: